Tirzepatide (Mounjaro) 5mg

5 (41)

Tirzepatide (Mounjaro) is a dual GLP-1 and GIP receptor agonist used to manage type 2 diabetes and assist with weight loss by improving blood sugar control and reducing appetite. It is administered via a once-weekly subcutaneous injection. Common side effects include nausea, diarrhea, and vomiting. Consult your healthcare provider for proper dosage and monitoring.

In stock

Free shipping on orders over 250 CAD FAQs.

Return Policy.

Restriction.

Overview

Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account